Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15176 - 15200 of 15375 in total
Experimental
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Investigational
Experimental
Displaying drugs 15176 - 15200 of 15375 in total